L C Ong Selected Research

L C Ong Research Topics

4	Neoplasms (Cancer) 02/2012 - 09/2009
2	Leukemia 02/2012 - 11/2011
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2012 - 11/2011
1	Polycythemia Vera 02/2012
1	Hepatomegaly 11/2011
1	Neoplasm Metastasis (Metastasis) 11/2011
1	Splenomegaly 11/2011
1	Hepatocellular Carcinoma (Hepatoma) 09/2009
1	Neural Tube Defects (Exencephaly) 12/2008

2	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 11/2011 - 11/2011
1	14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA 02/2012
1	fms-Like Tyrosine Kinase 3IBA 11/2011
1	pyrimidineIBA 11/2011
1	Sunitinib (Sutent)FDA Link 09/2009
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2009
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2009
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2008

1	Oral Administration 11/2011